|
Dibrompropamidine
|
DB13548 |
|
|
4-dimethylaminophenol
|
DB13549 |
|
|
Capivasertib
|
DB12218 |
[Capivasertib has been investigated for the treatment of Metastatic Breast Cancer.] |
|
GSK-424887
|
DB12219 |
[Gsk424887 has been used in trials studying the basic science and treatment of Depressive Disorder and Anxiety Disorder.] |
|
Mitobronitol
|
DB13543 |
|
|
Landiolol
|
DB12212 |
[Landiolol has been used in trials studying the treatment of Pharmacokinetics/Dynamics Study.] |
|
AZD-4017
|
DB14875 |
[AZD-4017 is under investigation in clinical trial NCT01173471 (A Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-ocular Pressure).] |
|
Cergutuzumab amunaleukin
|
DB14874 |
[Cergutuzumab amunaleukin is under investigation in clinical trial NCT02004106 (A Study to Evaluate Safety, Pharmacokinetics, and Efficacy of RO6895882 in Participants With Advanced and/or Metastatic Solid Tumors).] |
|
Etaracizumab
|
DB12213 |
[Etaracizumab has been investigated for the treatment of Psoriasis, Renal Cell Carcinoma, Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer, and Stage III Renal Cell Cancer.] |
|
Ethenzamide
|
DB13544 |
|
|
Lintuzumab
|
DB14877 |
[Lintuzumab is under investigation in clinical trial NCT00016159 (Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia).] |
|
Isobromindione
|
DB13545 |
|
|
Luseogliflozin
|
DB12214 |
[Luseogliflozin has been used in trials studying the treatment of Diabetes Melltius, Type 2.] |
|
Nizofenone
|
DB13546 |
|
|
TAS-116
|
DB14876 |
[TAS-116 is under investigation in clinical trial NCT02965885 (A Study of TAS-116 in Patients With Solid Tumors).] |
|
Xentuzumab
|
DB14871 |
[Xentuzumab is under investigation in clinical trial NCT02191891 (Xentuzumab (BI 836845) Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)).] |
|
PF-5190457
|
DB14870 |
[PF-5190457 is under investigation in clinical trial NCT01522807 (A Study Of Three PF-05190457 Formulations In Healthy Volunteers).] |
|
Isepamicin
|
DB13540 |
|
|
Enadenotucirev
|
DB14873 |
[Enadenotucirev is under investigation in clinical trial NCT02636036 (Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors).] |
|
Iprazochrome
|
DB13541 |
|
